| pubmed-article:12101492 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12101492 | lifeskim:mentions | umls-concept:C0242402 | lld:lifeskim |
| pubmed-article:12101492 | lifeskim:mentions | umls-concept:C0205487 | lld:lifeskim |
| pubmed-article:12101492 | lifeskim:mentions | umls-concept:C0009488 | lld:lifeskim |
| pubmed-article:12101492 | lifeskim:mentions | umls-concept:C0033105 | lld:lifeskim |
| pubmed-article:12101492 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:12101492 | pubmed:dateCreated | 2002-7-8 | lld:pubmed |
| pubmed-article:12101492 | pubmed:abstractText | To statistically pool prevalence estimates of all studies on co-morbid psychiatric disorders in samples of opioid addicts. | lld:pubmed |
| pubmed-article:12101492 | pubmed:language | ger | lld:pubmed |
| pubmed-article:12101492 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12101492 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12101492 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12101492 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:12101492 | pubmed:issn | 0303-4259 | lld:pubmed |
| pubmed-article:12101492 | pubmed:author | pubmed-author:RehmJürgenJ | lld:pubmed |
| pubmed-article:12101492 | pubmed:author | pubmed-author:FreiAdrianA | lld:pubmed |
| pubmed-article:12101492 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12101492 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:12101492 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12101492 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12101492 | pubmed:pagination | 258-62 | lld:pubmed |
| pubmed-article:12101492 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12101492 | pubmed:meshHeading | pubmed-meshheading:12101492... | lld:pubmed |
| pubmed-article:12101492 | pubmed:meshHeading | pubmed-meshheading:12101492... | lld:pubmed |
| pubmed-article:12101492 | pubmed:meshHeading | pubmed-meshheading:12101492... | lld:pubmed |
| pubmed-article:12101492 | pubmed:meshHeading | pubmed-meshheading:12101492... | lld:pubmed |
| pubmed-article:12101492 | pubmed:meshHeading | pubmed-meshheading:12101492... | lld:pubmed |
| pubmed-article:12101492 | pubmed:meshHeading | pubmed-meshheading:12101492... | lld:pubmed |
| pubmed-article:12101492 | pubmed:meshHeading | pubmed-meshheading:12101492... | lld:pubmed |
| pubmed-article:12101492 | pubmed:meshHeading | pubmed-meshheading:12101492... | lld:pubmed |
| pubmed-article:12101492 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12101492 | pubmed:articleTitle | [The prevalence of psychiatric co-morbidity among opioid addicts]. | lld:pubmed |
| pubmed-article:12101492 | pubmed:affiliation | Institut für Suchtforschung, Zürich, Schweiz. | lld:pubmed |
| pubmed-article:12101492 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12101492 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:12101492 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:12101492 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12101492 | lld:pubmed |
